Our study shows that mutational burden estimates, CIN/aneuploidy markers, and co-occurring CCND1 and CDKN2A mutations in advanced stage oro- and hypopharyngeal HNSCC are associated with patient outcomes. This evidence concerns the gene CDKN2A and cervical squamous intraepithelial neoplasia.